The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(6-ethoxy-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-4-yl)benzoic acid ID: ALA5208087
PubChem CID: 164673710
Max Phase: Preclinical
Molecular Formula: C21H21NO3
Molecular Weight: 335.40
Associated Items:
Names and Identifiers Canonical SMILES: CCOc1cccc2c1N[C@@H](c1cccc(C(=O)O)c1)[C@H]1CC=C[C@@H]21
Standard InChI: InChI=1S/C21H21NO3/c1-2-25-18-11-5-10-17-15-8-4-9-16(15)19(22-20(17)18)13-6-3-7-14(12-13)21(23)24/h3-8,10-12,15-16,19,22H,2,9H2,1H3,(H,23,24)/t15-,16+,19+/m1/s1
Standard InChI Key: DXIHVMJOYZAEOU-GJYPPUQNSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-3.2130 0.9965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4984 1.4088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7866 0.9970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7866 0.1718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4967 -0.2399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2130 0.1681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0720 1.4095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3575 0.9969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3575 0.1718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0720 -0.2407 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2556 1.5490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9004 2.2165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0798 2.3027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6554 1.9929 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
0.4676 0.9969 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.4967 -1.0650 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7821 -1.4776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7821 -2.3027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3570 -0.2407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0718 0.1716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7839 -0.2403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7839 -1.0657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0736 -1.4776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3570 -1.0694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4984 0.1721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2130 -0.2403 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4984 0.9973 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
8 7 1 0
9 8 1 0
10 9 1 0
4 10 1 0
8 11 1 0
7 12 1 0
12 13 2 0
13 11 1 0
7 14 1 1
8 15 1 1
5 16 1 0
16 17 1 0
17 18 1 0
9 19 1 6
20 19 2 0
21 20 1 0
22 21 2 0
23 22 1 0
19 24 1 0
24 23 2 0
25 21 1 0
25 26 1 0
25 27 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 335.40Molecular Weight (Monoisotopic): 335.1521AlogP: 4.61#Rotatable Bonds: 4Polar Surface Area: 58.56Molecular Species: ACIDHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.14CX Basic pKa: 3.34CX LogP: 3.44CX LogD: 0.70Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.80Np Likeness Score: -0.45
References 1. Goebel GL, Hohnen L, Borgelt L, Hommen P, Qiu X, Lightfoot H, Wu P.. (2022) Small molecules with tetrahydroquinoline-containing Povarov scaffolds as inhibitors disrupting the Protein-RNA interaction of LIN28-let-7., 228 [PMID:34883291 ] [10.1016/j.ejmech.2021.114014 ]